A novel role for 3, 4-dichloropropionanilide (DCPA) in the inhibition of prostate cancer cell migration, proliferation, and hypoxia-inducible factor 1alpha expression
2006
DCPA's Role in Prostate Cancer Cell Behavior
publication
Evidence: moderate
Author Information
Author(s): Jiang Bing-Hua, Liu Ling-Zhi, Schafer Rosana, Flynn Daniel C, Barnett John B
Primary Institution: West Virginia University
Hypothesis
Does DCPA inhibit prostate cancer cell migration, proliferation, and HIF-1α expression?
Conclusion
DCPA can inhibit prostate cancer cell migration, proliferation, and HIF-1α expression, suggesting that DCPA could be potentially used for therapeutic purposes for prostate cancer in the future.
Supporting Evidence
- DCPA inhibited the migration and proliferation of DU145 and PC-3 prostate cancer cells.
- DCPA decreased HIF-1α expression by affecting its protein stability.
- DCPA treatment did not increase cell death, indicating its effects are not due to toxicity.
Takeaway
DCPA is a compound that helps stop prostate cancer cells from moving and growing, which could help treat cancer.
Methodology
Transwell assay for cell migration and immunoblotting for protein expression.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website